Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/Akt signaling.

[1]  Hui Sun Leong,et al.  Targeting Cancer Stem Cell Plasticity Through Modulation of Epidermal Growth Factor and Insulin‐Like Growth Factor Receptor Signaling in Head and Neck Squamous Cell Cancer , 2014, Stem cells translational medicine.

[2]  A. Abrantes,et al.  Effect of Amniotic Membrane Proteins in Human Cancer Cell Lines: An Exploratory Study , 2014, The Journal of Membrane Biology.

[3]  A. Belfiore,et al.  The Emerging Role of Insulin and Insulin-Like Growth Factor Signaling in Cancer Stem Cells , 2014, Front. Endocrinol..

[4]  Sung-Hoon Kim,et al.  Umbilical cord tissue-derived mesenchymal stem cells induce apoptosis in PC-3 prostate cancer cells through activation of JNK and downregulation of PI3K/AKT signaling , 2014, Stem Cell Research & Therapy.

[5]  S. Russell,et al.  Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth. , 2013, Journal of hepatology.

[6]  Helen Shen.  Stricter standards sought to curb stem-cell confusion , 2013, Nature.

[7]  Liheng Peng,et al.  Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway , 2013, British Journal of Cancer.

[8]  M. Peppelenbosch,et al.  Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma , 2013, Carcinogenesis.

[9]  M. O’Connor-McCourt,et al.  IGFBP-4 anti-angiogenic and anti-tumorigenic effects are associated with anti-cathepsin B activity. , 2013, Neoplasia.

[10]  A. Dhawan,et al.  Intraportal transplantation of human bone marrow mesenchymal stem cells in pigs with fulminant hepatic failure , 2013, Hepatology.

[11]  Zhong-yu Wang,et al.  Effect of bone marrow mesenchymal stem cells on hepatocellular carcinoma in microcirculation , 2013, Tumor Biology.

[12]  B. Wang,et al.  Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. , 2013, Stem Cells and Development.

[13]  P. Lam,et al.  Carbenoxolone enhances TRAIL-induced apoptosis through the upregulation of death receptor 5 and inhibition of gap junction intercellular communication in human glioma. , 2013, Stem cells and development.

[14]  P. Lam,et al.  Human Bone Marrow‐Derived Mesenchymal Stem Cells Suppress Human Glioma Growth Through Inhibition of Angiogenesis , 2013, Stem cells.

[15]  Wenxiu Zhao,et al.  Efficacy of mesenchymal stem cells derived from human adipose tissue in inhibition of hepatocellular carcinoma cells in vitro. , 2012, Cancer biotherapy & radiopharmaceuticals.

[16]  Armand Keating,et al.  Mesenchymal stromal cells: new directions. , 2012, Cell stem cell.

[17]  G. Scagliotti,et al.  The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors. , 2012, Cancer treatment reviews.

[18]  M. Choolani,et al.  Human umbilical cord wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro , 2012, Journal of cellular biochemistry.

[19]  F. Izzo,et al.  BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy , 2012, Cell Death and Disease.

[20]  Xueru Mu,et al.  IGF-1 receptor is down-regulated by sunitinib induces MDM2-dependent ubiquitination , 2011, FEBS open bio.

[21]  P. Fisher,et al.  Insulin-like Growth Factor–Binding Protein-7 Functions as a Potential Tumor Suppressor in Hepatocellular Carcinoma , 2011, Clinical Cancer Research.

[22]  T. Pressiani,et al.  Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenib , 2011, Expert review of anticancer therapy.

[23]  M. Andreeff,et al.  Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth? , 2010, Stem cells.

[24]  A. Zhu,et al.  The role of signaling pathways in the development and treatment of hepatocellular carcinoma , 2010, Oncogene.

[25]  M. Wicha,et al.  Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase , 2010, Head & neck.

[26]  Y. Xia,et al.  Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice , 2010, Oncogene.

[27]  Derek Y. Chiang,et al.  IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. , 2010, Journal of hepatology.

[28]  Mahesh Choolani,et al.  Neo-vascularization and bone formation mediated by fetal mesenchymal stem cell tissue-engineered bone grafts in critical-size femoral defects. , 2010, Biomaterials.

[29]  D. Wakefield,et al.  The effect of mesenchymal stem cell conditioned media on corneal stromal fibroblast wound healing activities , 2009, British Journal of Ophthalmology.

[30]  R. Casper,et al.  Human embryonic stem cells secrete soluble factors that inhibit cancer cell growth , 2009, Cell proliferation.

[31]  C. Venot,et al.  Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma , 2009, Clinical Cancer Research.

[32]  Jeffrey M Karp,et al.  Mesenchymal stem cell homing: the devil is in the details. , 2009, Cell stem cell.

[33]  K. Kang,et al.  Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model. , 2009, Cytotherapy.

[34]  Yoon-Koo Kang,et al.  Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. , 2009, The Lancet. Oncology.

[35]  M. Gnecchi,et al.  Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.

[36]  M. Karin,et al.  NF-κB signaling, liver disease and hepatoprotective agents , 2008, Oncogene.

[37]  P. Schirmacher,et al.  Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. , 2008, World journal of gastroenterology.

[38]  Michael R Rosen,et al.  Mesenchymal Stem Cells Support Migration, Extracellular Matrix Invasion, Proliferation, and Survival of Endothelial Cells In Vitro , 2007, Stem cells.

[39]  J. Harper,et al.  Insulin‐like growth factor ligands, receptors, and binding proteins in cancer , 2005, The Journal of pathology.

[40]  O. Lee,et al.  In vitro hepatic differentiation of human mesenchymal stem cells , 2004, Hepatology.

[41]  Kai Breuhahn,et al.  Molecular Profiling of Human Hepatocellular Carcinoma Defines Mutually Exclusive Interferon Regulation and Insulin-Like Growth Factor II Overexpression , 2004, Cancer Research.

[42]  M. Mastrogiacomo,et al.  Gene expression profile of human bone marrow stromal cells determined by restriction fragment differential display analysis , 2004, Journal of cellular biochemistry.

[43]  G. Minuk,et al.  The expression of insulin-like growth factor binding proteins in human hepatocellular carcinoma , 2000, Molecular and Cellular Biochemistry.

[44]  Bernd Stadler,et al.  Pilot Study of Elevated Levels of Insulin-Like Growth Factor-Binding Protein-2 as Indicators of Hepatocellular Carcinoma , 2003, Hormone Research in Paediatrics.

[45]  Tomoyuki Masuda,et al.  M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan , 2002, Hepatology.

[46]  H. Huynh,et al.  A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[47]  M. Uemura,et al.  Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. , 2002, Cancer letters.

[48]  M. Binoux,et al.  A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. , 1996, Endocrinology.

[49]  Tony Hunter,et al.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.

[50]  N. Nishida,et al.  Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. , 1994, Cancer research.